Related references
Note: Only part of the references are listed.Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
David A. Lipson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A phase III study of triple therapy with budesonide/glycopyrrolate/ formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol
Klaus F. Rabe et al.
RESPIRATORY MEDICINE (2019)
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial
Kenneth R. Chapman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhaled corticosteroid containing combinations and mortality in COPD
Jorgen Vestbo et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Triple therapy trials in COPD: a precision medicine opportunity
Samy Suissa et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease A Randomized Controlled Trial
Ian S. Stone et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Peter T. Daley-Yates
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Helgo Magnussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
Samy Suissa et al.
THORAX (2012)
Exacerbation frequency and course of COPD
David M. G. Halpin et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Cardiovascular events in patients with COPD: TORCH Study results
Peter M. A. Calverley et al.
THORAX (2010)
Mortality in the 4-Year Trial of Tiotropium (UPLIFT) in Patients with Chronic Obstructive Pulmonary Disease
Bartolome Celli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD
C-G. Lofdahl et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inhaled corticosteroids and mortality in COPD
Christine Macie et al.
CHEST (2006)
Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease
DD Sin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Share Paper
